Not applicableStudy completedNCT00089739What this trial is testingImmune Indicators of UveitisWho this might be right forGITRGITR LigandUveitis+2 more National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Study completedNCT02697591What this trial is testingINCAGN01876 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 100
Early research (Phase 1)Ended earlyNCT01216436What this trial is testingLocal Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic MelanomaWho this might be right forMetastatic Melanoma Duke University 2
Early research (Phase 1)Ended earlyNCT04465487What this trial is testingStudy of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and Neck Regeneron Pharmaceuticals 38
Early research (Phase 1)Ended earlyNCT03799003What this trial is testingASP1951 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Study completedNCT02740270What this trial is testingPhase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and LymphomasWho this might be right forSolid TumorsLymphomas Novartis Pharmaceuticals 92
Not applicableUnknownNCT03763201What this trial is testingGlucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Benha University 50
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Early research (Phase 1)Looking for participantsNCT04470024What this trial is testingPhase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCCWho this might be right forCancer of the Head and Neck Providence Health & Services 56
Early research (Phase 1)Study completedNCT01239134What this trial is testingTrial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid TumorsWho this might be right forUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies Leap Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225039What this trial is testingAnti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent GlioblastomaWho this might be right forGlioblastoma University of Pennsylvania 39
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Early research (Phase 1)Study completedNCT02583165What this trial is testingA Study in Adult Subjects With Select Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors MedImmune LLC 40